Large portfolio Mylan Belgium Viatris offers a broad catalog of over 200 products spanning branded medicines, OTC, biosimilars, and generics, presenting multiple cross-sell opportunities across therapeutic areas such as cardiovascular, gastroenterology, women’s health, CNS, pain, dermatology, and vaccination.

Hospital footprint Strong presence in the Belgian hospital sector with almost all hospitals utilizing their products, signaling ongoing expansion potential in hospital procurement channels and potential for facility-based formulary opportunities.

Access and volume Impressive reach with 11 million Belgians served and 17 million medicine boxes annually, indicating consistent demand dynamics and potential for volume-based pricing, bundled offerings, or contract manufacturing partnerships.

Brand and generics mix Diverse exposure to both original brands like Iso-Betadine, Lipanthyl, and Epipen alongside generics and biosimilars, enabling targeted campaigns to hospitals, clinics, and pharmacies based on product lifecycle and reimbursement events.

Growth lever Recent business transformation under Viatris and ongoing emphasis on accessibility positions the company to pursue strategic partnerships, licensing, or co-development collaborations to expand market share in Belgium and adjacent regions.